In Vitro Diagnostics (IVD) Quality Control Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

In Vitro Diagnostics (IVD) Quality Control Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

The report on in vitro diagnostics (IVD) quality control market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global in vitro diagnostics (IVD) quality control market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.Please Note: PDF E-mail from Publisher purchase option allows 1 - 5 users.


The report on the global in vitro diagnostics (IVD) quality control market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global in vitro diagnostics (IVD) quality control market to grow with a CAGR of 3.5% over the forecast period from 2020-2026. The study on in vitro diagnostics (IVD) quality control market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026. The report on in vitro diagnostics (IVD) quality control market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global in vitro diagnostics (IVD) quality control market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings. Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global in vitro diagnostics (IVD) quality control market over the period of 2018 to 2026. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider. Report Findings 1) Drivers • Rising prevalence of chronic diseases, diabetes, and obesity • Growing adoption of the third party for quality assessment support 2) Restraints • The cost associated with in vitro diagnostics is high 3) Opportunities • Rising number of clinical laboratories in emerging countries Research Methodology A) Primary Research Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include 1. Key Opinion Leaders associated with Infinium Global Research 2. Internal and External subject matter experts 3. Professionals and participants from the industry Our primary research respondents typically include 1. Executives working with leading companies in the market under review 2. Product/brand/marketing managers 3. CXO level executives 4. Regional/zonal/ country managers 5. Vice President level executives. B) Secondary Research Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include 1. Company reports and publications 2. Government/institutional publications 3. Trade and associations journals 4. Databases such as WTO, OECD, World Bank, and among others. 5. Websites and publications by research agencies Segment Covered The global in vitro diagnostics (IVD) quality control market is segmented on the basis of products and services, application, manufacturer type, and end user . The Global In Vitro Diagnostics (IVD) Quality Control Market by Products and Services • Data Management Solutions • Quality Control Products o Uri-based Controls o Whole-blood-Based Controls o Other IVD Quality Controls • Quality Assurance Services The Global In Vitro Diagnostics (IVD) Quality Control Market by Application • Immunochemistry • Microbiology • Coagulation/Hemostasis • Clinical Chemistry • Molecular Diagnostics • Hematology • Other Applications The Global In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type • OEMS • Third-party Control Manufacturers o Independent Manufacturer Controls o InstrumentSpecific Controls The Global In Vitro Diagnostics (IVD) Quality Control Market by End User • Clinical Laboratories • Hospitals • Research and Academic Institutes • Other End Users Company Profiles The companies covered in the report include • Roche Diagnostics • Thermo Fisher Scientific Inc. • Helena Laboratories • Randox Laboratories Ltd • Seracare Life Sciences, Inc. • Sero AS • Technopath Clinical Diagnostics • Ortho Clinical Diagnostics, Inc. • Abbott Laboratories Inc. • Bio-Rad Laboratories, Inc. What does this report deliver? 1. Comprehensive analysis of the global as well as regional markets of the in vitro diagnostics (IVD) quality control market. 2. Complete coverage of all the segments in the in vitro diagnostics (IVD) quality control market to analyze the trends, developments in the global market and forecast of market size up to 2026. 3. Comprehensive analysis of the companies operating in the global in vitro diagnostics (IVD) quality control market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company. 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. In Vitro Diagnostics (IVD) Quality Control Market Highlights
2.2. In Vitro Diagnostics (IVD) Quality Control Market Projection
2.3. In Vitro Diagnostics (IVD) Quality Control Market Regional Highlights
3. Global In Vitro Diagnostics (IVD) Quality Control Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the In Vitro Diagnostics (IVD) Quality Control Market
3.4. Porter's Five Forces Analysis
3.5. IGR-Growth Matrix Analysis
3.5.1. IGR-Growth Matrix Analysis by Products and Services
3.5.2. IGR-Growth Matrix Analysis by Application
3.5.3. IGR-Growth Matrix Analysis by Manufacturer Type
3.5.4. IGR-Growth Matrix Analysis by End User
3.5.5. IGR-Growth Matrix Analysis by Region
3.6. Value Chain Analysis of In Vitro Diagnostics (IVD) Quality Control Market
4. In Vitro Diagnostics (IVD) Quality Control Market Macro Indicator Analysis
5. Global In Vitro Diagnostics (IVD) Quality Control Market by Product and Services
5.1. Data Management Solutions
5.2. Quality Control Products
5.2.1. Uri-based Control
5.2.2.Whole-blood-Based Controls
5.2.3. Other IVD Quality Controls
5.3. Quality Assurance Services
6. Global In Vitro Diagnostics (IVD) Quality Control Market by Application
6.1. Immunochemistry
6.2. Microbiology
6.3. Coagulation/Hemostasis
6.4. Clinical Chemistry
6.5. Molecular Diagnostics
6.6. Hematology
6.7. Other Applications
7. Global In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type
7.1. OEMS
7.2. Third-Party Control Manufacturers
7.2.1. Independent Manufacturer Controls
7.2.2. Instrument-Specific Controls
8. Global In Vitro Diagnostics (IVD) Quality Control Market by End User
8.1. Clinical Laboratories
8.2. Hospitals
8.3. Research and Academic Institutes
8.4. Other End Users
9. Global In Vitro Diagnostics (IVD) Quality Control Market by Region 2020-2026
9.1. North America
9.1.1. North America In Vitro Diagnostics (IVD) Quality Control Market by Products and Services
9.1.2. North America In Vitro Diagnostics (IVD) Quality Control Market by Application
9.1.3. North America In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type
9.1.4. North America In Vitro Diagnostics (IVD) Quality Control Market by End User
9.1.5. North America In Vitro Diagnostics (IVD) Quality Control Market by Country
9.2. Europe
9.2.1. Europe In Vitro Diagnostics (IVD) Quality Control Market by Products and Services
9.2.2. Europe In Vitro Diagnostics (IVD) Quality Control Market by Application
9.2.3. Europe In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type
9.2.4. Europe In Vitro Diagnostics (IVD) Quality Control Market by End User
9.2.5. Europe In Vitro Diagnostics (IVD) Quality Control Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market by Products and Services
9.3.2. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market by Application
9.3.3. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type
9.3.4. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market by End User
9.3.5. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market by Country
9.4. RoW
9.4.1. RoW In Vitro Diagnostics (IVD) Quality Control Market by Products and Services
9.4.2. RoW In Vitro Diagnostics (IVD) Quality Control Market by Application
9.4.3. RoW In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type
9.4.4. RoW In Vitro Diagnostics (IVD) Quality Control Market by End User
9.4.5. RoW In Vitro Diagnostics (IVD) Quality Control Market by Sub-region
10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global In Vitro Diagnostics (IVD) Quality Control Market
10.2. Companies Profiles
10.2.1. Roche Diagnostics
10.2.2. Thermo Fisher Scientific Inc.
10.2.3. Helena Laboratories
10.2.4. Randox Laboratories Ltd
10.2.5. Seracare Life Sciences, Inc.
10.2.6. Sero AS
10.2.7. Technopath Clinical Diagnostics
10.2.8. Ortho Clinical Diagnostics, Inc.
10.2.9. Abbott Laboratories Inc.
10.2.10. Bio-Rad Laboratories, Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook